Literature DB >> 15047716

Glutamatergic chemical transmission: look! Here, there, and anywhere.

Yoshinori Moriyama1, Akitsugu Yamamoto.   

Abstract

Vesicular glutamate transporter (VGLUT) is responsible for the active transport of L-glutamate in synaptic vesicles and thus plays an essential role in the glutamatergic chemical transmission in the central nervous system. VGLUT comprises three isoforms, VGLUT1, 2, and 3, and is a potential marker for the glutamatergic phenotype. Recent studies indicated that VGLUT is also expressed in non-neuronal cells, and localized with various organelles such as synaptic-like microvesicles in the pineal gland, and hormone-containing secretory granules in endocrine cells. L-Glutamate is stored in these organelles, secreted upon various forms of stimulation, and then acts as a paracrine-like modulator. Thus, VGLUTs highlight a novel framework of glutamatergic signaling and reveal its diverse modes of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047716     DOI: 10.1093/jb/mvh018

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  19 in total

Review 1.  Glutamate transporter 1: target for the treatment of alcohol dependence.

Authors:  P S S Rao; Y Sari
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Glutamatergic elements in an excitability and circumnutation mechanism.

Authors:  Maria Stolarz; Elzbieta Król; Halina Dziubinska
Journal:  Plant Signal Behav       Date:  2010-09-01

3.  Identification of a vesicular nucleotide transporter.

Authors:  Keisuke Sawada; Noriko Echigo; Narinobu Juge; Takaaki Miyaji; Masato Otsuka; Hiroshi Omote; Akitsugu Yamamoto; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

4.  Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum.

Authors:  Teri M Furlong; Laura H Corbit; Robert A Brown; Bernard W Balleine
Journal:  Addict Biol       Date:  2017-07-14       Impact factor: 4.280

Review 5.  Genetic inactivation of the vesicular glutamate transporter 2 (VGLUT2) in the mouse: what have we learnt about functional glutamatergic neurotransmission?

Authors:  Asa Wallén-Mackenzie; Hanna Wootz; Hillevi Englund
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

6.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

7.  Role of mechanical stress-induced glutamate signaling-associated molecules in cytodifferentiation of periodontal ligament cells.

Authors:  Chiharu Fujihara; Satoru Yamada; Nobuhiro Ozaki; Nobuo Takeshita; Harumi Kawaki; Teruko Takano-Yamamoto; Shinya Murakami
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

8.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum.

Authors:  Pablo R Brumovsky; David R Robinson; Jun-Ho La; Kim B Seroogy; Kerstin H Lundgren; Kathryn M Albers; Michael E Kiyatkin; Rebecca P Seal; Robert H Edwards; Masahiko Watanabe; Tomas Hökfelt; G F Gebhart
Journal:  J Comp Neurol       Date:  2011-11-01       Impact factor: 3.215

10.  Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.

Authors:  Masahiro Takahashi; Toshihide Mizoguchi; Shunsuke Uehara; Yuko Nakamichi; Shuhua Yang; Hiroko Naramoto; Teruhito Yamashita; Yasuhiro Kobayashi; Minoru Yamaoka; Kiyofumi Furusawa; Nobuyuki Udagawa; Takashi Uematsu; Naoyuki Takahashi
Journal:  J Bone Miner Metab       Date:  2008-12-13       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.